Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow fever vaccination

Arch Neurol. 2012 Jan;69(1):144; author reply 144-5. doi: 10.1001/archneurol.2011.1519.
No abstract available

Publication types

  • Comment

MeSH terms

  • Female
  • Humans
  • Male
  • Multiple Sclerosis / immunology*
  • Yellow Fever / prevention & control*
  • Yellow Fever Vaccine / immunology*

Substances

  • Yellow Fever Vaccine